Many inflammatory indicators (amyloid A, CRP, matrix metalloproteinases, myeloperoxidase, phospholipase A2, and others) [83] and some OS indicators (malondialdehyde, protein carbonyls, and NO metabolites) [84] have been identified as risk markers for stroke severity and prognosis. This evidence concerns the gene MPO and stroke disorder.